Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Observe Medical ASA ( (DE:OM50) ) has issued an update.
Observe Medical ASA has announced a positive market reception for its UnoMeter Safeti Plus product, which has gained significant traction since its first delivery in January 2025. The company has re-established sales in countries representing 85% of Convatec’s 2021 market for the product, with orders received from 27 countries and multiple orders from 16 of them. With an annualized order intake of approximately NOK 30 million, the company is well-positioned to advance its operational and strategic goals, supported by a successful private placement and substantial backing from creditors.
More about Observe Medical ASA
Observe Medical is a Nordic medtech company headquartered in Oslo, Norway, specializing in developing, marketing, and selling innovative medical technology products globally. The company focuses on improving patient welfare and outcomes, enhancing clinical data accuracy, and promoting positive health economics, with a strong emphasis on urine measurement and ultrasound technologies.
Average Trading Volume: 116,998
Current Market Cap: NOK21.57M
For an in-depth examination of OM50 stock, go to TipRanks’ Stock Analysis page.